NovoCure (NVCR) Expected to Announce Quarterly Earnings on Thursday

NovoCure ( NASDAQ:NVCR – Get Free Report ) will likely be issuing its quarterly earnings data before the market opens on Thursday, April 24th. Analysts expect the company to announce earnings of ($0.47) per share and revenue of $147.

57 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link . NovoCure ( NASDAQ:NVCR – Get Free Report ) last issued its earnings results on Thursday, February 27th.



The medical equipment provider reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.

27). The company had revenue of $161.27 million during the quarter, compared to analysts’ expectations of $161.

30 million. NovoCure had a negative return on equity of 41.48% and a negative net margin of 25.

93%. On average, analysts expect NovoCure to post $-1 EPS for the current fiscal year and $-2 EPS for the next fiscal year. NovoCure Price Performance Shares of NVCR opened at $15.

83 on Thursday. NovoCure has a 1-year low of $11.70 and a 1-year high of $34.

13. The firm has a fifty day simple moving average of $19.18 and a two-hundred day simple moving average of $21.

53. The company has a current ratio of 1.49, a quick ratio of 1.

44 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.

74 billion, a PE ratio of -11.31 and a beta of 0.65.

Analyst Ratings Changes Get Our Latest Analysis on NVCR About NovoCure ( Get Free Report ) NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company’s TTFields devices include Optune Gio and Optune Lua. Further Reading Receive News & Ratings for NovoCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovoCure and related companies with MarketBeat.

com's FREE daily email newsletter ..